Literature DB >> 2198049

Methods of assessing the effect of drug therapy on quality of life.

P A Ganz1.   

Abstract

Mesh:

Substances:

Year:  1990        PMID: 2198049     DOI: 10.2165/00002018-199005040-00001

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  32 in total

1.  Measurement of the clinical status of patients with breast cancer: evidence for the validity of self assessment with linear analogue scales.

Authors:  N F Boyd; P J Selby; H J Sutherland; S Hogg
Journal:  J Clin Epidemiol       Date:  1988       Impact factor: 6.437

2.  A modular approach to quality-of-life assessment in cancer clinical trials.

Authors:  N K Aaronson; M Bullinger; S Ahmedzai
Journal:  Recent Results Cancer Res       Date:  1988

3.  Conceptual and methodological problems in research on the quality of life in clinical medicine.

Authors:  J Siegrist; A Junge
Journal:  Soc Sci Med       Date:  1989       Impact factor: 4.634

4.  Do we need a new end point in clinical trials today?

Authors: 
Journal:  J Natl Cancer Inst       Date:  1989-07-19       Impact factor: 13.506

5.  Measuring disease-specific quality of life in clinical trials.

Authors:  G H Guyatt; C Bombardier; P X Tugwell
Journal:  CMAJ       Date:  1986-04-15       Impact factor: 8.262

6.  Methodology in behavioral and psychosocial cancer research. Conceptualizing disease impact and treatment outcomes.

Authors:  J E Ware
Journal:  Cancer       Date:  1984-05-15       Impact factor: 6.860

7.  A pilot study of the Functional Living Index-Cancer (FLIC) Scale for the assessment of quality of life for metastatic lung cancer patients. An Eastern Cooperative Oncology Group study.

Authors:  D M Finkelstein; B R Cassileth; P D Bonomi; J C Ruckdeschel; E Z Ezdinli; J M Wolter
Journal:  Am J Clin Oncol       Date:  1988-12       Impact factor: 2.339

8.  Auranofin therapy and quality of life in patients with rheumatoid arthritis. Results of a multicenter trial.

Authors:  C Bombardier; J Ware; I J Russell; M Larson; A Chalmers; J L Read
Journal:  Am J Med       Date:  1986-10       Impact factor: 4.965

9.  The effects of antihypertensive therapy on the quality of life.

Authors:  S H Croog; S Levine; M A Testa; B Brown; C J Bulpitt; C D Jenkins; G L Klerman; G H Williams
Journal:  N Engl J Med       Date:  1986-06-26       Impact factor: 91.245

10.  Quality of life assessment of patients in extremity sarcoma clinical trials.

Authors:  P H Sugarbaker; I Barofsky; S A Rosenberg; F J Gianola
Journal:  Surgery       Date:  1982-01       Impact factor: 3.982

View more
  5 in total

Review 1.  Ketanserin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension and peripheral vascular disease.

Authors:  R N Brogden; E M Sorkin
Journal:  Drugs       Date:  1990-12       Impact factor: 9.546

Review 2.  The potential of biotechnology to improve the quality of life of patients with renal failure.

Authors:  W E Bloembergen; A Laupacis
Journal:  Drug Saf       Date:  1991 Jan-Feb       Impact factor: 5.606

Review 3.  Enalapril: a review of quality-of-life and pharmacoeconomic aspects of its use in heart failure and mild to moderate hypertension.

Authors:  M I Wilde; H M Bryson; K L Goa
Journal:  Pharmacoeconomics       Date:  1994-08       Impact factor: 4.981

Review 4.  Quality of life. 2. Economic analysis of drug therapies.

Authors:  S V Pham; J R Draugalis
Journal:  Pharm World Sci       Date:  1993-04-23

Review 5.  Measuring the effects of medication use on health-related quality of life in patients with rheumatoid arthritis. A review.

Authors:  M B Nichol; A S Harada
Journal:  Pharmacoeconomics       Date:  1999-11       Impact factor: 4.981

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.